Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine-guided hydration for AKI prevention in CRS-HIPEC
NCT05939193Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of furosemide in acute kidney injury (AKI) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of acute kidney injury at 7 days. Started Jul 2023; status: completed.
02
Drugs
furosemide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05939193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05939193.